4 articles on Asia-Pacific.
Lobbying Transparency · Comparative Analysis How 30+ Jurisdictions Are Rewriting the Rules of Influence — From Handshakes to Hashtags The global architecture of lobbying transparency has undergone an unprecedented transformation in the first quarter of the 21st century. What was once a niche concern for a handful of North American jurisdictions has evolved into a […]
Navigate Japan's complex pharmaceutical market with our expert guide. Understand the core challenges of the MHLW-led drug pricing system, key repricing rules like Market Expansion Repricing, and major policy trends to watch.
This practical guide explains the UFLPA Entity List and its impact on US importers. Follow our step-by-step framework for UFLPA compliance to avoid costly shipment detentions, protect your brand, and build a resilient supply chain.
US pharma faces growing risks from Chinese API dependency. This guide explains why traditional methods fail and outlines a proactive framework for China API export monitoring across regulatory, political, and market signals to protect your supply chain.